Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial. [PDF]
Dhawan R +6 more
europepmc +1 more source
Early Initiation of Sacubitril/Valsartan in Intracerebral Hemorrhage With Refractory Hypertension and Chronic Heart Failure: A Case Report. [PDF]
Nishino T +4 more
europepmc +1 more source
Linking FHIR-Based Medication Data to a Computable Algorithm for Heart Medication Optimization: A Critical Component of Any Medication Learning Health System. [PDF]
LeGrand J +5 more
europepmc +1 more source
The Heart-Gut Axis in Heart Failure: The Role of Next-Generation Pharmacological Therapies. [PDF]
Salerno ENM +13 more
europepmc +1 more source
Efficacy of sacubitril/valsartan sodium combined with simvastatin in treating chronic heart failure with arrhythmia and its effects on IL-6, IL-8, and TNF-α. [PDF]
Li J, Wang Z.
europepmc +1 more source
The Primary Outcome Is Positive - Is That Good Enough? [PDF]
Pocock, Stuart J, Stone, Gregg W
core +1 more source
Effectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study. [PDF]
Maury E +4 more
europepmc +1 more source
Quantitative Evaluation of Cardiac Function Improvement by Conventional Cardiology Drug Regimens Combined with Sacubitril/Valsartan Sodium in Heart Failure Patients. [PDF]
Liu C, Lai C, Xu M, Wang Y.
europepmc +1 more source
The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient. [PDF]
Kinoshita H +13 more
europepmc +1 more source
Predictors of reverse cardiac remodeling after sacubitril/valsartan in heart failure with reduced ejection fraction. [PDF]
Yoon M +9 more
europepmc +1 more source

